These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 438332)
1. Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism. Carey RM; Ayers CR; Vaughan ED; Peach MJ; Herf SM J Clin Invest; 1979 Apr; 63(4):718-26. PubMed ID: 438332 [TBL] [Abstract][Full Text] [Related]
2. Activity of (des-Aspartyl1)-angiotensin II and angiotensin II in man. Differences in blood pressure and adrenocortical response during normal and low sodium intake. Carey RM; Vaughan ED; Peach MJ; Ayers CR J Clin Invest; 1978 Jan; 61(1):20-31. PubMed ID: 338631 [TBL] [Abstract][Full Text] [Related]
3. Organ specificity of angiotensin II and Des-aspartyl angiotensin II in the conscious rat. Campbell WB; Pettinger WA J Pharmacol Exp Ther; 1976 Aug; 198(2):450-6. PubMed ID: 948036 [TBL] [Abstract][Full Text] [Related]
4. Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension. Dluhy RG; Bavli SZ; Leung FK; Solomon HS; Moore TJ; Hollenberg NK; Williams GH J Clin Invest; 1979 Nov; 64(5):1270-6. PubMed ID: 500810 [TBL] [Abstract][Full Text] [Related]
5. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism. Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298 [TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics and surgery outcomes of unilateral nodular adrenal hyperplasia in primary aldosteronism: study of 145 cases]. Wu JC; Tang ZY; Zhang W; Ling DY; Hou RF; Wang WQ; Li XY; Ning G Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3302-5. PubMed ID: 17313818 [TBL] [Abstract][Full Text] [Related]
7. (Des-Asp1) angiotensin I: a study of its pressor and steroidogenic activities in conscious rats. Campbell WB; Schmitz JM; Itskovitz HD Endocrinology; 1977 Jan; 100(1):46-51. PubMed ID: 187407 [TBL] [Abstract][Full Text] [Related]
8. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension]. Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950 [TBL] [Abstract][Full Text] [Related]
9. Effect of captopril on aldosterone response to potassium infusion in primary aldosteronism. Fallo F; Chouman M; Pagotto U; Pistorello M Miner Electrolyte Metab; 1991; 17(3):185-9. PubMed ID: 1779941 [TBL] [Abstract][Full Text] [Related]
10. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone. Carey RM; Thorner MO; Ortt EM J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333 [TBL] [Abstract][Full Text] [Related]
11. [des-Asp1]angiotensin II in the dog: blood levels and effect on aldosterone. Semple PF; Nicholls MG; Tree M; Fraser R Endocrinology; 1978 Oct; 103(4):1476-82. PubMed ID: 744159 [TBL] [Abstract][Full Text] [Related]
12. In vitro studies in primary aldosteronism: baseline steroid production and aldosterone responses to ACTH and angiotensin II. Pham-Huu-Trung MT; Duclos JM; Pagny JY; Bogyo A; Leneuve P; Girard F Acta Endocrinol (Copenh); 1988 Jan; 117(1):135-44. PubMed ID: 2837882 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension. Gordon RD; Gomez-Sanchez CE; Hamlet SM; Tunny TJ; Klemm SA J Hypertens Suppl; 1987 Dec; 5(5):S103-6. PubMed ID: 2832571 [TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. Rossi GP; Belfiore A; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Semplicini A; Agabiti-Rosei E; Pessina AC; Mantero F; J Hypertens; 2007 Jul; 25(7):1433-42. PubMed ID: 17563566 [TBL] [Abstract][Full Text] [Related]
15. Primary aldosteronism: renaissance of a syndrome. Young WF Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946 [TBL] [Abstract][Full Text] [Related]
16. [The clinical use of captopril in the diagnosis and treatment of primary aldosteronism]. Li J Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Feb; 18(1):2-4, 60. PubMed ID: 2204520 [TBL] [Abstract][Full Text] [Related]
17. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension. Wisgerhof M; Brown RD J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin antagonists with increased specificity for the renal vasculature. Taub KJ; Caldicott WJ; Hollenberg NK J Clin Invest; 1977 Mar; 59(3):528-35. PubMed ID: 190270 [TBL] [Abstract][Full Text] [Related]
19. Zona fasciculata-like histotype and aldosterone response to upright posture are not related in aldosterone-producing adenomas. Fallo F; Barzon L; Biasi F; Altavilla G; Boscaro M; Sonino N Exp Clin Endocrinol Diabetes; 1998; 106(1):74-8. PubMed ID: 9516064 [TBL] [Abstract][Full Text] [Related]
20. Hypotension in end-stage renal disease: effect of postural change, exercise and angiotensin II infusion on blood pressure and plasma concentrations of angiotensin II, aldosterone and arginine vasopressin in hypotensive patients with chronic renal failure treated by dialysis. Sørensen SS; Danielsen H; Jespersen B; Pedersen EB Clin Nephrol; 1986 Dec; 26(6):288-96. PubMed ID: 3802595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]